Deutscher Ärzteverlag GmbH, Redaktion Deutsches Ärzteblatt: Pharmakokinetische Wechselwirkungen: Das Interaktionspotenzial der Fluorchinolone. Hrsg.: Holger Petri. 2016 (aerzteblatt.de [abgerufen am 24. Februar 2018]).
Xilin Zhao, Robert J. Kerns, Muhammad Malik, Karl Drlica: Quinolone-Mediated Bacterial Death. In: Antimicrobial Agents and Chemotherapy. Band52, Nr.2, 1. Februar 2008, S.385–392, doi:10.1128/AAC.01617-06, PMID 17724149 (asm.org [abgerufen am 28. Januar 2019]).
W. B. Graninger, W. Graninger, R. Ullrich, M. Köller, L. Erlacher: Effects of ciprofloxacin and ofloxacin on adult human cartilage in vitro. In: Antimicrobial Agents and Chemotherapy. Band41, Nr.11, 1. November 1997, S.2562–2565, doi:10.1128/AAC.41.11.2562, PMID 9371369 (asm.org [abgerufen am 28. Januar 2019]).
Jerzy Duszyński, Krzysztof Zabłocki, Rafał Kozieł: Calcium Signals Are Affected by Ciprofloxacin as a Consequence of Reduction of Mitochondrial DNA Content in Jurkat Cells. In: Antimicrobial Agents and Chemotherapy. Band50, Nr.5, 1. Mai 2006, S.1664–1671, doi:10.1128/AAC.50.5.1664-1671.2006, PMID 16641433 (asm.org [abgerufen am 20. Januar 2019]).
Donald A. Redelmeier, Hong Lu, Nick Daneman: Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study. In: BMJ Open. Band5, Nr.11, 1. November 2015, S.e010077, doi:10.1136/bmjopen-2015-010077, PMID 26582407 (bmj.com [abgerufen am 27. Januar 2019]).
cjhp-online.ca
Anita Rachlis, Sandra Knowles, Elizabeth Phillips, William Cornish, Andrew E. Simor: Analysis of Spontaneous Reports of Hypoglycemia and Hyperglycemia Associated with Marketed Systemic Fluoroquinolones Made to the Canadian Adverse Drug Reaction Monitoring Program. In: The Canadian Journal of Hospital Pharmacy. Band57, Nr.1, 2004, doi:10.4212/cjhp.v57i1.345 (cjhp-online.ca [abgerufen am 19. Februar 2019]).
doi.org
Shmuel Fuchs, Zvi Simon, Mayer Brezis: Fatal hepatic failure associated with ciprofloxacin. In: The Lancet. 343, 1994, S. 738, doi:10.1016/S0140-6736(94)91624-1.
Xilin Zhao, Robert J. Kerns, Muhammad Malik, Karl Drlica: Quinolone-Mediated Bacterial Death. In: Antimicrobial Agents and Chemotherapy. Band52, Nr.2, 1. Februar 2008, S.385–392, doi:10.1128/AAC.01617-06, PMID 17724149 (asm.org [abgerufen am 28. Januar 2019]).
S. Ewig, P. Tuschy , G. Fätkenheuer: Diagnostik und Therapie der Legionellen-Pneumonie. In: Pneumologie. Band56, 2002, S.695–703, doi:10.1055/s-2002-35548.
W. B. Graninger, W. Graninger, R. Ullrich, M. Köller, L. Erlacher: Effects of ciprofloxacin and ofloxacin on adult human cartilage in vitro. In: Antimicrobial Agents and Chemotherapy. Band41, Nr.11, 1. November 1997, S.2562–2565, doi:10.1128/AAC.41.11.2562, PMID 9371369 (asm.org [abgerufen am 28. Januar 2019]).
Judith Sendzik, Mehdi Shakibaei, Monika Schäfer-Korting, Ralf Stahlmann: Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. In: Toxicology. Band212, Nr.1, 15. August 2005, S.24–36, doi:10.1016/j.tox.2005.04.002.
Donald A. Redelmeier, Hong Lu, Nick Daneman: Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study. In: BMJ Open. Band5, Nr.11, 1. November 2015, S.e010077, doi:10.1136/bmjopen-2015-010077, PMID 26582407 (bmj.com [abgerufen am 27. Januar 2019]).
Shmuel Fuchs, Zvi Simon, Mayer Brezis: Fatal hepatic failure associated with ciprofloxacin. In: The Lancet. 343, 1994, S. 738, doi:10.1016/S0140-6736(94)91624-1.
S. Badal, Y. F. Her, L. J. Maher: Non-antibiotic effects of fluoroquinolones in mammalian cells. In: The Journal of biological chemistry. [elektronische Veröffentlichung vor dem Druck] Juli 2015, doi:10.1074/jbc.M115.671222, PMID 26205818.
J. Samyde, P. Petit, D. Hillaire-Buys, J. L. Faillie: Quinolone antibiotics and suicidal behavior: analysis of the World Health Organization’s adverse drug reactions database and discussion of potential mechanisms. In: Psychopharmacology. April 2016, doi:10.1007/s00213-016-4300-3.
Elvia Canseco, Theodoros Kelesidis: Quinolone-induced Hypoglycemia: A Life-threatening but Potentially Reversible Side Effect. In: The American Journal of Medicine. Band123, Nr.2, 1. Februar 2010, S.e5–e6, doi:10.1016/j.amjmed.2009.07.022.
Anita Rachlis, Sandra Knowles, Elizabeth Phillips, William Cornish, Andrew E. Simor: Analysis of Spontaneous Reports of Hypoglycemia and Hyperglycemia Associated with Marketed Systemic Fluoroquinolones Made to the Canadian Adverse Drug Reaction Monitoring Program. In: The Canadian Journal of Hospital Pharmacy. Band57, Nr.1, 2004, doi:10.4212/cjhp.v57i1.345 (cjhp-online.ca [abgerufen am 19. Februar 2019]).
H. Ghaly, K. Hatlapatka, I. Rustenbeck: The insulinotropic effect of fluoroquinolones is counteracted by their inhibitory effect on pancreatic beta cell energy metabolism. In: Diabetologie und Stoffwechsel. Band5, Nr.3, 2010, doi:10.1055/s-0030-1255203.
L'. Majtánová, V. Majtán: Quinolone effects in the SOS chromotest and in the synthesis of biomacromolecules. In: Folia Microbiologica. Band41, Nr.3, 1. Juni 1996, S.233–236, doi:10.1007/BF02814622.
N Gorla, H Garcı́a Ovando, I Larripa: Chromosomal aberrations in human lymphocytes exposed in vitro to enrofloxacin and ciprofloxacin. In: Toxicology Letters. Band104, Nr.1, 11. Januar 1999, S.43–48, doi:10.1016/S0378-4274(98)00230-6.
Jerzy Duszyński, Krzysztof Zabłocki, Rafał Kozieł: Calcium Signals Are Affected by Ciprofloxacin as a Consequence of Reduction of Mitochondrial DNA Content in Jurkat Cells. In: Antimicrobial Agents and Chemotherapy. Band50, Nr.5, 1. Mai 2006, S.1664–1671, doi:10.1128/AAC.50.5.1664-1671.2006, PMID 16641433 (asm.org [abgerufen am 20. Januar 2019]).
Peter Karran, Peter Macpherson, Reto Brem, Matthew Peacock: DNA repair inhibition by UVA photoactivated fluoroquinolones and vemurafenib. In: Nucleic Acids Research. Band42, Nr.22, 16. Dezember 2014, S.13714–13722, doi:10.1093/nar/gku1213 (oup.com [abgerufen am 20. Januar 2019]).
Zumrut Dogan, Aymelek Cetin, Ebru Elibol, Nigar Vardi, Yusuf Turkoz: Effects of ciprofloxacin and quercetin on fetal brain development: a biochemical and histopathological study. In: The Journal of Maternal-Fetal & Neonatal Medicine. 10. Januar 2018, S.1–9, doi:10.1080/14767058.2017.1418222.
Fatemeh Zobeiri, Siamak Salami, Rajabali Sadrkhanlou, Tahmineh Peirouvi: Role of Mitochondria in Ciprofloxacin-Induced Apoptosis in Murine Sperm Cells. In: Reproductive Sciences. Band20, Nr.9, 18. Februar 2013, S.1090–1095, doi:10.1177/1933719113477482.
D. Raoult, G. Verghese, P. Jasper, M. Mathai, L. Verghese: Case reports: scrub typhus during pregnancy in India. In: Transactions of The Royal Society of Tropical Medicine and Hygiene. Band97, Nr.5, 1. Oktober 2003, S.570–572, doi:10.1016/S0035-9203(03)80032-9 (oup.com [abgerufen am 11. Februar 2019]).
Patent DE3142854: 1-Cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel. Angemeldet am 9. Oktober 1981, veröffentlicht am 11. Mai 1983, Anmelder: Bayer, Erfinder: Klaus Grohe, Hans-Joachim Zeiler, Karl Georg Metzger.
Patent DE3033157: 7-Amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel. Angemeldet am 3. September 1980, veröffentlicht am 1. April 1982, Anmelder: Bayer, Erfinder: Klaus Grohe, Hans-Joachim Zeiler, Karl Georg Metzger.
María Tamayo, Rebeca Santiso, Jaime Gosalvez, Germán Bou, José Luis Fernández: Rapid assessment of the effect of ciprofloxacin on chromosomal DNA from Escherichia coli using an in situ DNA fragmentation assay. In: BMC Microbiology. Band9, Nr.13, April 2009, PMC 2670838 (freier Volltext).
Xilin Zhao, Robert J. Kerns, Muhammad Malik, Karl Drlica: Quinolone-Mediated Bacterial Death. In: Antimicrobial Agents and Chemotherapy. Band52, Nr.2, 1. Februar 2008, S.385–392, doi:10.1128/AAC.01617-06, PMID 17724149 (asm.org [abgerufen am 28. Januar 2019]).
María Tamayo, Rebeca Santiso, Jaime Gosalvez, Germán Bou, José Luis Fernández: Rapid assessment of the effect of ciprofloxacin on chromosomal DNA from Escherichia coli using an in situ DNA fragmentation assay. In: BMC Microbiology. Band9, Nr.13, April 2009, PMID 19364397.
W. B. Graninger, W. Graninger, R. Ullrich, M. Köller, L. Erlacher: Effects of ciprofloxacin and ofloxacin on adult human cartilage in vitro. In: Antimicrobial Agents and Chemotherapy. Band41, Nr.11, 1. November 1997, S.2562–2565, doi:10.1128/AAC.41.11.2562, PMID 9371369 (asm.org [abgerufen am 28. Januar 2019]).
Yong-Taek Jun, Hee-Jung Kim, Min-Jin Song, Ji-Hyang Lim, Dong-Gun Lee: In Vitro Effects of Ciprofloxacin and Roxithromycin on Apoptosis of Jurkat T Lymphocytes. In: Antimicrobial Agents and Chemotherapy. Band47, Nr.3, März 2003, PMID 12604563.
R. J. Williams, E. Attia, T. L. Wickiewicz, J. A. Hannafin: The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism. In: The American Journal of Sports Medicine. Band28, Nr.3, Mai 2000, PMID 10843129.
J. W. Lawrence, S. Darkin-Rattray, F. Xie, A. H. Neims, T. C. Rowe: 4-Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cells. In: Journal of Cellular Biochemistry. Band51, Nr.2, Februar 1993, PMID 8440750.
R. Koziel, J. Szczepanowska, A. Magalska, K. Piwocka, J. Duszynski: Ciprofloxacin inhibits proliferation and promotes generation of aneuploidy in Jurkat cells. In: Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society. Band61, Nr.2, April 2010, PMID 20436225.
Rafał Kozieł, Krzysztof Zabłocki, Jerzy Duszyński: Calcium Signals Are Affected by Ciprofloxacin as a Consequence of Reduction of Mitochondrial DNA Content in Jurkat Cells. In: Antimicrobial Agents and Chemotherapy. Band50, Nr.5, Mai 2006, PMID 16641433.
TOMASZ KLOSKOWSKI, NATALIA GURTOWSKA, JOANNA OLKOWSKA, JAKUB MARCIN NOWAK, JAN ADAMOWICZ: Ciprofloxacin is a potential topoisomerase II inhibitor for the treatment of NSCLC. In: International Journal of Oncology. Band41, Nr.6, Oktober 2012, PMID 23042104.
G Höffken, H Lode, C Prinzing, K Borner, P Koeppe: Pharmacokinetics of ciprofloxacin after oral and parenteral administration. In: Antimicrobial Agents and Chemotherapy. Band27, Nr.3, März 1985, PMID 3158275.
R Wise, R M Lockley, M Webberly, J Dent: Pharmacokinetics of intravenously administered ciprofloxacin. In: Antimicrobial Agents and Chemotherapy. Band26, Nr.2, August 1984, PMID 6486762.
Donald A. Redelmeier, Hong Lu, Nick Daneman: Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study. In: BMJ Open. Band5, Nr.11, 1. November 2015, S.e010077, doi:10.1136/bmjopen-2015-010077, PMID 26582407 (bmj.com [abgerufen am 27. Januar 2019]).
Krzysztof Michalak, Aleksandra Sobolewska-Włodarczyk, Marcin Włodarczyk, Justyna Sobolewska, Piotr Woźniak: Treatment of the Fluoroquinolone-Associated Disability: The Pathobiochemical Implications. In: Oxidative Medicine and Cellular Longevity. Band2017, 2017, PMID 29147464.
Kamaljeet Kaur, Raja Fayad, Arpit Saxena, Norma Frizzell, Anindya Chanda: Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social network. In: The Journal of Community and Supportive Oncology. Band14, Nr.2, Februar 2016, PMID 26955658.
S. Badal, Y. F. Her, L. J. Maher: Non-antibiotic effects of fluoroquinolones in mammalian cells. In: The Journal of biological chemistry. [elektronische Veröffentlichung vor dem Druck] Juli 2015, doi:10.1074/jbc.M115.671222, PMID 26205818.
Victor E Reviglio, Melinda A Hakim, Jae K Song, Terrence P O’Brien: Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea. In: BMC Ophthalmology. Band3, 6. Oktober 2003, PMID 14529574.
Wissam K Kabbara, Wijdan H Ramadan, Peggy Rahbany, Souhaila Al-Natour: Evaluation of the appropriate use of commonly prescribed fluoroquinolones and the risk of dysglycemia. In: Therapeutics and Clinical Risk Management. Band11, Nr.22, 2015, PMID 25960658.
Hany Ghaly, Christine Kriete, Seher Sahin, Anja Pflöger, Ulrike Holzgrabe: The insulinotropic effect of fluoroquinolones. In: Biochemical Pharmacology. Band77, Nr.6, 2009, PMID 19073153.
Stephen J. Telfer: Fluoroquinolone antibiotics and type 2 diabetes mellitus. In: Medical Hypotheses. Band83, Nr.3, 2014, PMID 24947193.
P. Burke, S. R. Burne: Allergy associated with ciprofloxacin. In: BMJ. Band 320, Nummer 7236, März 2000, S. 679, PMID 10710576. PMC 27310 (freier Volltext).
John G Cooper, Knut Harboe, Sofia K Frost, Øyvind Skadberg: Ciprofloxacin interacts with thyroid replacement therapy. In: BMJ : British Medical Journal. Band330, Nr.7498, April 2005, PMID 15860826.
S W Mamber, B Kolek, K W Brookshire, D P Bonner, J Fung-Tomc: Activity of quinolones in the Ames Salmonella TA102 mutagenicity test and other bacterial genotoxicity assays. In: Antimicrobial Agents and Chemotherapy. Band37, Nr.2, Februar 1993, S.213–217, PMID 8452351, PMC 187641 (freier Volltext).
A. Mukherjee, S. Sen, K. Agarwal: Ciprofloxacin: mammalian DNA topoisomerase type II poison in vivo. In: Mutation Research. Band301, Nr.2, Februar 1993, S.87–92, PMID 7678175.
Jerzy Duszyński, Krzysztof Zabłocki, Rafał Kozieł: Calcium Signals Are Affected by Ciprofloxacin as a Consequence of Reduction of Mitochondrial DNA Content in Jurkat Cells. In: Antimicrobial Agents and Chemotherapy. Band50, Nr.5, 1. Mai 2006, S.1664–1671, doi:10.1128/AAC.50.5.1664-1671.2006, PMID 16641433 (asm.org [abgerufen am 20. Januar 2019]).
Fatemeh Zobeiri, Rajab-Ali Sadrkhanlou, Siamak Salami, Karim Mardani, Abbas Ahmadi: The effect of ciprofloxacin on sperm DNA damage, fertility potential and early embryonic development in NMRI mice. In: Veterinary Research Forum. Band3, Nr.2, 2012, S.131–135, PMID 25653759, PMC 4312808 (freier Volltext).
Fatemeh Zobeiri, Rajab-Ali Sadrkhanlou, Siamak Salami, Karim Mardani: Long-Term Effect of Ciprofloxacin on Testicular Tissue: Evidence for Biochemical and Histochemical Changes. In: International Journal of Fertility & Sterility. Band6, Nr.4, 2013, S.294–303, PMID 24520454, PMC 3850316 (freier Volltext).
Peter Karran, Peter Macpherson, Reto Brem, Matthew Peacock: DNA repair inhibition by UVA photoactivated fluoroquinolones and vemurafenib. In: Nucleic Acids Research. Band42, Nr.22, 16. Dezember 2014, S.13714–13722, doi:10.1093/nar/gku1213 (oup.com [abgerufen am 20. Januar 2019]).
D. Raoult, G. Verghese, P. Jasper, M. Mathai, L. Verghese: Case reports: scrub typhus during pregnancy in India. In: Transactions of The Royal Society of Tropical Medicine and Hygiene. Band97, Nr.5, 1. Oktober 2003, S.570–572, doi:10.1016/S0035-9203(03)80032-9 (oup.com [abgerufen am 11. Februar 2019]).
Quinolone Antibacterials (= Handbook of Experimental Pharmacology). Springer-Verlag, Berlin Heidelberg 1998, ISBN 3-642-80366-0 (springer.com [abgerufen am 31. Januar 2019]).
